Maravai LifeSciences Inc... (MRVI)

MRVI trades at $2.62, 31.0% above the near-term max pain of $2 expiring Sep 19, 2025 (34 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($0.5-$95), signaling increased put positioning or downside protection. Key magnetic zone at 2 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for MRVI shows a downward trend from 95 to 0.5, indicating bearish sentiment or hedging activity. The 543% spread signals divergent expectations across timeframes. Most levels below 2.62 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.